A mouse model for latent tuberculosis

Scandinavian Journal of Infectious Diseases

Volumn 30, Issue 1, 1998, Pages 59-68

  Phyu, Sabai ^a   Mustafa, Tehmina ^a   Hofstad, Tor ^a   Nilsen, Rune ^a   Fosse, Richard ^b   Bjune, Gunnar ^c  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; TUBERCULOSIS;

ANIMALS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; MICE; MICE, INBRED STRAINS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 0031838485     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655498750002321     Document Type: Article

References (57)

1. Bloom BR, Fine PEM. The BCG experience: Implication for future vaccines against TB. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press 1994: 531-57.
2. Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698-702.
3. Sutherland I, Lindgren I. The protective effect of BCG vaccination as indicated by autopsy studies. Tubercle 1979; 60: 225-31.
4. Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle 1976; 57: 275-99.
5. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745-9.
6. Weissler JC. Southwestern internal medicine conference: Tuberculosis-immunopathogenesis and therapy. Am J Med Sci 1993; 305: 52-65.
7. Groth-Petersen E, Knudsen J, Wilbek E. Epidemiological basis of tuberculosis eradication in an advanced country. Bull WHO 1959; 21: 5-49.
8. Stead WW. Pathogenesis of a first episode of chronic pulmonary TB in man: Recrudescence of residuals of the primary infection or exogenous reinfection. Am Rev Respir Dis 1967; 95: 729-45.
9. Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987; 107: 837-42.
10. Tabet SR, Goldbaum GM, Hooton TM, Eisenach KD, Cave MD, Nolan CM. Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus. J Infect Dis 1994; 169: 189-92.
11. Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus: An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231-5.
12. Coronado VG, Beck-Sague CM, Hutton MD, Davis BJ, Nicholas P, Villareal C, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993; 168: 1052-5.
13. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, Drucker E, Bloom BR. Transmission of tuberculosis in New York City: An analysis by DNA fingerprinting and conventional epidemiologic methods. New Engl J Med 1994; 330: 1710-6.
14. Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco: A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703-9.
15. Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley SM. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tuberc Lung Dis 1996; 77: 407-13.
16. Genewein A, Telenti A, Bernasconi C, Mordasini C, Weiss S, Maurer A-M. et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993; 342: 841-4.
17. Styblo K. Epidemiology of tuberculosis: In selected papers. Roy Netherl Tuberc Assoc 1991; 24: 1-136.
18. Snider DE. Tuberculosis: the world situation. History of disease and efforts to combat it. In: Porter JDH, McAdam KPWJ, editors. Tuberculosis back to the future. London: John Wiley & Sons Ltd, 1994: 13-31.
19. Smith PG, Moss AR. Epidemilogy of tuberculosis. In: B. R. Bloom, editor. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press, 1994: 47-59.
20. Medlar FM. Primary and reinfection tuberculosis as the cause of death in adults. An analysis of 100 consecutive necropsies. Am Rev Tuberc 1947; 55: 517-28.
21. Hopewell PC. Overview of clinical Tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis. protection and control. Washington, DC: ASM Press, 1995: 25-46.
22. Davies PDO. Adult tuberculosis: In: Hart CA, Beeching NJ, Duerden BI, editors. Tuberculosis into the next century. J Med Microbiol, 1996: 44: 1-34.
23. Murray CJL, Styblo K, Rouillon A, Tuberculosis. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6-24.
24. Styblo K. Epidemiology of tuberculosis. VEB Gustav Fischer Verlag Jena: The Hague 1984.
25. Hart PD, Rees RJW. Enhancing effect of cortisone on tuberculosis in the mouse. Lancet 1950; 2: 391-5.
26. Hart PD, Rees RJW. Effect of Macrocyclon in acute and chronic pulmonary tuberculous infection in mice as shown by viable and total bacterial counts. Br J Exp Pathol 1960; 41: 414-21.
27. Rees RJW, Hart PD. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. Br J Exp Pathol 1961; 42: 83-8.
28. McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial resistance. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med 1966; 123: 445-68.
29. McCune RM, Feldmann FM, McDermott W. Microbial resistance. II. Characteristics of the sterile state of tubercle bacilli. J Exp Med 1966; 123: 469-86.
30. Brown DH, Miles BA, Zwilling BS. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: Establishment of latency and reactivation. Infect Immunol 1995; 63: 2243-7.
31. Orme IM. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis 1988; 137: 716-8.
32. Data sheet from Bomholtgård Breeding and Research Centre Ltd., Denmark 1995.
33. Mshana RN, Humber DP, Harboe M, Belehu A. Demonstration of Mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique. Clin Immunol Immunopathol 1983; 29: 359-68.
34. Wiley EL, Mulhollan TJ, Beck B, Tyndall JA, Freeman RG. Polyclonal antibodies raised against Bacillus Calmette-Guerin. Mycobacterium duvalii, and Mycobacterium paratuberculosis used to detect mycobacteria in tissue with the use of immunohistochemical techniques. Am J Clin Pathol 1990; 94: 307-12.
35. Opie EL, Aronson JD. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med 1927; 4: 1-21.
36. Feldman WH, Baggenstoss AH. The residual infectivity of the primary complex of tuberculosis. Am J Pathol 1938; 14: 473-93.
37. Griffith AS. Types of tubercle bacilli in human tuberculosis. J Patho Bact 1929; 32: 813-40.
38. Schwabacher H, Wilson GS. The inoculation of minimal doses of tubercle bacilli into guinea-pigs, rabbits and mice. Tubercle 1937; 18: 442-54.
39. Wayne LG. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am Rev Respir Dis 1976; 114: 807-11.
40. Wayne LG. Synchronized replication of Mycobacterium tuberculosis, Infect Immunol 1977; 17: 528-30.
41. Wayne LG, Lin K-Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immunol 1982; 37: 1042-9.
42. Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 1994; 13: 908-14.
43. Wayne LG, Hayes LG. An in vitro model for the sequential study of shiftdown of Mycobacterium tuberculosis through 2 stages of nonreplicating persistence. Infect Immunol 1996; 64: 2062-9.
44. DeMaio J, Zhang Y, Ko C, Young DB, Bishai WR. A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1996; 93: 2790-4.
45. Lefford MJ. Diseases in the mice and rats. In: Kubica GP, Wayne LG, editors. The Mycobacteria - a source book. New York: Marcel Dekker, 1984: 947-74.
46. Nyka W, Faherty JF, Malone L C, Kiser JS. A histological study of the pathogenesis of tuberculosis in mice experimentally infected with bacilli of human type. Exp Med Surg 1954; 12: 367-429.
47. Yamamura Y, Walter A, Bloch H. Bacterial populations in experimental murine tuberculosis. I. Studies in normal mice. J Infect Dis 1960; 106: 211-22.
48. Mayer E, Jackson ER, Whiteside ES, Alverson C. Experimental embolic pulmonary tuberculosis in mice. Am Rev Tuberc 1954; 69: 419-42.
49. Raleigh GW, Youmans GP. The use of mice in experimental chemotherapy of Tuberculosis: II. Pathology and pathogenesis. J Infect Dis 1948; 82: 205-20.
50. Vandiviere HM, Loring WE, Melvin I, Willis S. The treated pulmonary lesion and its tubercle bacillus. II. The death and resurrection. Am J Med Sci 1956; 232: 30-7.
51. Dagnæs-Hansen F. Laboratory animal genetics and genetic monitoring. In: Svendsen P, Hau J, editors. Handbook of laboratory animal science. Selection and handling of animals in biomedical research, vol. 1. Boca Raton, FL: CRC Press, Inc., 1994.
52. Buschman E, Apt AS, Nickonenko BV, Moroz AM, Averbakh MH, Skamene E. Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice. Springer Semin Immunopathol 1988; 10: 319-36.
53. Orme IM, Collins FM. Mouse model of tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington, DC; ASM Press, 1995: 113-34.
54. Costello R, Izumi T. Measurement of resistance to experimental tuberculosis in albino mice. J Exp Med 1971; 133: 362-75.
55. Abbas AK, Lichtman AH, Pober JS. Regulation of immune responses. In Cellular and molecular immunology. 2nd ed. Philadelphia: W.B. Saunders Co., 206-7 1994.
56. Conradt P, Kaufmann SHE. Impact of antigen-presenting cells on cytokine profiles of human Th clones established after stimulation with Mycobacterium tuberculosis antigens. Infect Immunol 1995; 63: 2079-81.
57. Youmans GP, Youmans AS. The relation between the size of the infecting dose of tubercle bacilli and the survival time of mice. Am Rev Tuberc 1951; 64: 534-40.